Cisplatin and Doxorubicin Induce Distinct Mechanisms of Ovarian Follicle Loss; Imatinib Provides Selective Protection Only against Cisplatin

Open Access

Peer-reviewed

Research Article

Stephanie Morgan,

Affiliation Centre for Integrative Physiology, University of Edinburgh, Edinburgh, Scotland, United Kingdom
⨯
Federica Lopes,

Affiliation Centre for Integrative Physiology, University of Edinburgh, Edinburgh, Scotland, United Kingdom
⨯
Charlie Gourley,

Affiliation Edinburgh Cancer Research Centre, University of Edinburgh, Edinburgh, Scotland, United Kingdom
⨯
Richard A. Anderson,

Affiliation MRC Centre for Reproductive Health, University of Edinburgh, Edinburgh, Scotland, United Kingdom
⨯
Norah Spears

* E-mail: nspears@staffmail.ed.ac.uk

Affiliation Centre for Integrative Physiology, University of Edinburgh, Edinburgh, Scotland, United Kingdom
⨯

Reader Comments (0)

Ovaries
Is the Subject Area "Ovaries" applicable to this article?

Thanks for your feedback.
Oocytes
Is the Subject Area "Oocytes" applicable to this article?

Thanks for your feedback.
Granulosa cells
Is the Subject Area "Granulosa cells" applicable to this article?

Thanks for your feedback.
Apoptosis
Is the Subject Area "Apoptosis" applicable to this article?

Thanks for your feedback.
Chemotherapy
Is the Subject Area "Chemotherapy" applicable to this article?

Thanks for your feedback.
Cancer treatment
Is the Subject Area "Cancer treatment" applicable to this article?

Thanks for your feedback.
Drug therapy
Is the Subject Area "Drug therapy" applicable to this article?

Thanks for your feedback.
Chemotherapeutic agents
Is the Subject Area "Chemotherapeutic agents" applicable to this article?

Thanks for your feedback.